Cargando…

Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1

Glutaric acidemia type 1 (GA1) is an inherited metabolic autosomal recessive disorder that is caused by a deficiency in glutaryl-CoA dehydrogenase (GCDH). Untreated patients suffer primarily from severe striatal damage. More than 250 variants in the GCDH gene have been reported with a variable frequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zayed, Hatem, El Khayat, Hamed, Tomoum, Hoda, Khalifa, Ola, Siddiq, Ehab, Mohammad, Shaimaa A., Gamal, Radwa, Shi, Zumin, Mosailhy, Ahmed, Zaki, Osama K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617250/
https://www.ncbi.nlm.nih.gov/pubmed/31062211
http://dx.doi.org/10.1007/s11011-019-00422-3
_version_ 1783433649219174400
author Zayed, Hatem
El Khayat, Hamed
Tomoum, Hoda
Khalifa, Ola
Siddiq, Ehab
Mohammad, Shaimaa A.
Gamal, Radwa
Shi, Zumin
Mosailhy, Ahmed
Zaki, Osama K.
author_facet Zayed, Hatem
El Khayat, Hamed
Tomoum, Hoda
Khalifa, Ola
Siddiq, Ehab
Mohammad, Shaimaa A.
Gamal, Radwa
Shi, Zumin
Mosailhy, Ahmed
Zaki, Osama K.
author_sort Zayed, Hatem
collection PubMed
description Glutaric acidemia type 1 (GA1) is an inherited metabolic autosomal recessive disorder that is caused by a deficiency in glutaryl-CoA dehydrogenase (GCDH). Untreated patients suffer primarily from severe striatal damage. More than 250 variants in the GCDH gene have been reported with a variable frequency among different ethnic groups. In this study, we aimed to characterize 89 Egyptian patients with GA1 and identify the variants in the 41 patients who were available for genotyping. All of our patients demonstrated clinical, neuroradiological, and biochemical characteristics that are consistent with a diagnosis of GA1. All patients presented with variable degrees of developmental delay ranging from mild to severe. Most of the 89 patients presented with acute onset type (71.9%), followed by insidious (19%) and asymptomatic (9%). A delay in diagnosis was inversely associated with macrocephaly. The prevalence rate ratio (PR) for macrocephaly that was associated with each 6-month delay was 0.95 (95%CI 0.91–0.99). However, high body weight was associated with a higher likelihood of having macrocephaly (PR 1.16, 95%CI 1.06–1.26 per 1 SD increment of Z score weight). However, body weight was inversely associated with the morbidity score. Consanguinity level was 64% among our patient’s cohort and was positively associated with the C5DC level (β (95%CI) 1.06 (0.12–1.99)). Forty-one patients were available for genotyping and were sequenced for the GCDH gene. We identified a total of 25 variants, of which the following six novel variants were identified: three missense variants, c.320G > T (p.Gly107Val), c.481C > T (p.Arg161Trp) and c.572 T > G (p.Met191Arg); two deletions, c.78delG (p.Ala27Argfs34) and c.1035delG (p.Gly346Alafs*11); and one indel, c.272_331del (p.Val91_Lys111delinsGlu). All of the novel variants were absent in the 300 normal chromosomes. The most common variant, c.*165A > G, was detected in 42 alleles, and the most commonly detected missense variant, c.1204C > T (p.Arg402Trp), was identified in 29 mutated alleles in 15/41 (34.2%) of patients. Our findings suggest that GA1 is not uncommon organic acidemia disease in Egypt; therefore, there is a need for supporting neonatal screening programs in Egypt. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11011-019-00422-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6617250
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-66172502019-07-28 Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1 Zayed, Hatem El Khayat, Hamed Tomoum, Hoda Khalifa, Ola Siddiq, Ehab Mohammad, Shaimaa A. Gamal, Radwa Shi, Zumin Mosailhy, Ahmed Zaki, Osama K. Metab Brain Dis Original Article Glutaric acidemia type 1 (GA1) is an inherited metabolic autosomal recessive disorder that is caused by a deficiency in glutaryl-CoA dehydrogenase (GCDH). Untreated patients suffer primarily from severe striatal damage. More than 250 variants in the GCDH gene have been reported with a variable frequency among different ethnic groups. In this study, we aimed to characterize 89 Egyptian patients with GA1 and identify the variants in the 41 patients who were available for genotyping. All of our patients demonstrated clinical, neuroradiological, and biochemical characteristics that are consistent with a diagnosis of GA1. All patients presented with variable degrees of developmental delay ranging from mild to severe. Most of the 89 patients presented with acute onset type (71.9%), followed by insidious (19%) and asymptomatic (9%). A delay in diagnosis was inversely associated with macrocephaly. The prevalence rate ratio (PR) for macrocephaly that was associated with each 6-month delay was 0.95 (95%CI 0.91–0.99). However, high body weight was associated with a higher likelihood of having macrocephaly (PR 1.16, 95%CI 1.06–1.26 per 1 SD increment of Z score weight). However, body weight was inversely associated with the morbidity score. Consanguinity level was 64% among our patient’s cohort and was positively associated with the C5DC level (β (95%CI) 1.06 (0.12–1.99)). Forty-one patients were available for genotyping and were sequenced for the GCDH gene. We identified a total of 25 variants, of which the following six novel variants were identified: three missense variants, c.320G > T (p.Gly107Val), c.481C > T (p.Arg161Trp) and c.572 T > G (p.Met191Arg); two deletions, c.78delG (p.Ala27Argfs34) and c.1035delG (p.Gly346Alafs*11); and one indel, c.272_331del (p.Val91_Lys111delinsGlu). All of the novel variants were absent in the 300 normal chromosomes. The most common variant, c.*165A > G, was detected in 42 alleles, and the most commonly detected missense variant, c.1204C > T (p.Arg402Trp), was identified in 29 mutated alleles in 15/41 (34.2%) of patients. Our findings suggest that GA1 is not uncommon organic acidemia disease in Egypt; therefore, there is a need for supporting neonatal screening programs in Egypt. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11011-019-00422-3) contains supplementary material, which is available to authorized users. Springer US 2019-05-06 2019 /pmc/articles/PMC6617250/ /pubmed/31062211 http://dx.doi.org/10.1007/s11011-019-00422-3 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Zayed, Hatem
El Khayat, Hamed
Tomoum, Hoda
Khalifa, Ola
Siddiq, Ehab
Mohammad, Shaimaa A.
Gamal, Radwa
Shi, Zumin
Mosailhy, Ahmed
Zaki, Osama K.
Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1
title Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1
title_full Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1
title_fullStr Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1
title_full_unstemmed Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1
title_short Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1
title_sort clinical, biochemical, neuroradiological and molecular characterization of egyptian patients with glutaric acidemia type 1
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617250/
https://www.ncbi.nlm.nih.gov/pubmed/31062211
http://dx.doi.org/10.1007/s11011-019-00422-3
work_keys_str_mv AT zayedhatem clinicalbiochemicalneuroradiologicalandmolecularcharacterizationofegyptianpatientswithglutaricacidemiatype1
AT elkhayathamed clinicalbiochemicalneuroradiologicalandmolecularcharacterizationofegyptianpatientswithglutaricacidemiatype1
AT tomoumhoda clinicalbiochemicalneuroradiologicalandmolecularcharacterizationofegyptianpatientswithglutaricacidemiatype1
AT khalifaola clinicalbiochemicalneuroradiologicalandmolecularcharacterizationofegyptianpatientswithglutaricacidemiatype1
AT siddiqehab clinicalbiochemicalneuroradiologicalandmolecularcharacterizationofegyptianpatientswithglutaricacidemiatype1
AT mohammadshaimaaa clinicalbiochemicalneuroradiologicalandmolecularcharacterizationofegyptianpatientswithglutaricacidemiatype1
AT gamalradwa clinicalbiochemicalneuroradiologicalandmolecularcharacterizationofegyptianpatientswithglutaricacidemiatype1
AT shizumin clinicalbiochemicalneuroradiologicalandmolecularcharacterizationofegyptianpatientswithglutaricacidemiatype1
AT mosailhyahmed clinicalbiochemicalneuroradiologicalandmolecularcharacterizationofegyptianpatientswithglutaricacidemiatype1
AT zakiosamak clinicalbiochemicalneuroradiologicalandmolecularcharacterizationofegyptianpatientswithglutaricacidemiatype1